Home / Tag Archives: finerenone

Tag Archives: finerenone

Low Potassium, Higher Diabetes Risk? A Surprising Clue From Heart Failure Research

Low potassium and diabetes risk illustrated with a glucose meter, potassium-rich foods, heart model, and pancreas.

Low potassium is usually viewed through a cardiovascular lens, especially in patients with heart failure. However, emerging evidence suggests clinicians may have another reason to pay attention. New research examining the relationship between hypokalemia and diabetes risk found that lower serum potassium levels were associated with a greater risk of …

Read More »

Beyond SGLT2 Inhibitors: Why Non-Steroidal MRAs Are Becoming the Third Pillar of Kidney Protection

Illustration of healthy kidneys with medication representing non-steroidal mineralocorticoid receptor antagonists alongside SGLT2 inhibitor therapy for diabetic kidney disease management.

For years, the treatment of diabetic kidney disease focused primarily on glycemic control and blood pressure management. More recently, SGLT2 inhibitors and GLP-1 receptor agonists have transformed the landscape by reducing kidney disease progression and cardiovascular events. However, another therapeutic class is rapidly gaining recognition. Non-steroidal mineralocorticoid receptor antagonists (MRAs) …

Read More »